278 related articles for article (PubMed ID: 3773152)
1. Cost and price of comparable branded and generic pharmaceuticals.
Bloom BS; Wierz DJ; Pauly MV
JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152
[TBL] [Abstract][Full Text] [Related]
2. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
3. Prescription prices under the New York generic substitution law.
Francetić I; Lasagna L; Weintraub M; Karch FE
Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
[TBL] [Abstract][Full Text] [Related]
4. Impact of brand drug discount cards on private insurer, government and patient expenditures.
Law MR; Chan FKI; Harrison M; Worthington HC
CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
[TBL] [Abstract][Full Text] [Related]
5. Who cares what it costs to dispense a Medicaid prescription?
Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
[TBL] [Abstract][Full Text] [Related]
6. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
7. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
8. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
Carroll NV; Rupp MT; Holdford DA
J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
[TBL] [Abstract][Full Text] [Related]
9. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
10. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
11. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
Johnsrud M; Lawson KA; Shepherd MD
J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
[TBL] [Abstract][Full Text] [Related]
13. Medicare prescription drug cards: effectiveness for patients with glaucoma.
Mahadevia AA; Nundy S; Frick KD; Jampel HD
Arch Ophthalmol; 2006 Aug; 124(8):1175-9. PubMed ID: 16908821
[TBL] [Abstract][Full Text] [Related]
14. The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.
Frank RG; Hicks A; Berndt ER
Med Care Res Rev; 2021 Oct; 78(5):585-590. PubMed ID: 32468959
[TBL] [Abstract][Full Text] [Related]
15. What Determines How Much Your Patient Pays for Their Medication in the United States?
Novack GD
Am J Ophthalmol; 2016 Jul; 167():48-51. PubMed ID: 27131775
[TBL] [Abstract][Full Text] [Related]
16. Savings from Canadian Internet pharmacies are limited.
Rothberg M
Ann Intern Med; 2006 Feb; 144(3):224; author reply 224-5. PubMed ID: 16461977
[No Abstract] [Full Text] [Related]
17. Prescription drug benefits: cost management issues for Medicare.
Fox PD
Health Care Financ Rev; 2003; 25(2):7-21. PubMed ID: 15124374
[TBL] [Abstract][Full Text] [Related]
18. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
19. State prescription drug price Web sites: how useful to consumers?
Tu HT; Corey CG
Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
[TBL] [Abstract][Full Text] [Related]
20. Trends and determinants of retail prescription drug costs.
Teasdale B; Nguyen A; van Meijgaard J; Schulman KA
Health Serv Res; 2022 Jun; 57(3):548-556. PubMed ID: 35211965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
